Statin rebound or withdrawal syndrome: Does it exist?

Current Atherosclerosis Reports

Volumn 13, Issue 1, 2011, Pages 23-30

  Pineda, Andres ^a   Cubeddu, Luigi X ^b  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b NOVA SOUTHEASTERN UNIVERSITY   (United States)

Author keywords

Acute coronary events; Acute ischemic stroke; Major vascular surgery; Statin withdrawal; Statins

Indexed keywords

ATORVASTATIN; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TIROFIBAN;

ACUTE CORONARY SYNDROME; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CARDIOGENIC SHOCK; CELL STRESS; CORONARY ARTERY DISEASE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG WITHDRAWAL; HEART ARREST; HEART DEATH; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; ISCHEMIC HEART DISEASE; LUNG EDEMA; MORTALITY; NEUROLOGIC DISEASE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; NONHUMAN; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PROGNOSIS; REBOUND; RISK REDUCTION; STROKE; SUBARACHNOID HEMORRHAGE; TREATMENT CONTRAINDICATION; VASCULAR SURGERY; WITHDRAWAL SYNDROME;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANIMALS; CARDIOVASCULAR DISEASES; DRUG MONITORING; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPOLIPIDEMIC AGENTS; MICE; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; RISK FACTORS; SUBSTANCE WITHDRAWAL SYNDROME; VASCULAR SURGICAL PROCEDURES;

EID: 79551571085     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-010-0148-x     Document Type: Article

References (37)

1. GN Levine JF Keaney JA Vita 1995 Cholesterol reduction in cardiovascular disease N Engl J Med 332 8 512 521 1:STN:280:DyaK2M7jtF2ksQ%3D%3D 10.1056/NEJM199502233320807 7830734
2. JA Farmer G Am Jr 1996 Current and future therapeutic approaches to hyperlipidemia Adv Pharmacol 35 79 114 1:CAS:528:DyaK28Xkt1ekt7g%3D 10.1016/S1054-3589(08)60275-6 8920205
3. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2002; 285:2486-2497.
4. U Laufs V La Fata J Plutzky JK Liao 1998 Upregulation of endothelial nitric oxide synthase by HMG CoA-reductase inhibitors Circulation 97 12 1129 1135 1:CAS:528:DyaK1cXisVWmsrY%3D 9537338 (Pubitemid 28152885)
5. M Endres U Laufs 2004 Effects of statins on endothelium and signaling mechanisms Stroke 35 11 Suppl 1 2708 2711 1:CAS:528:DC%2BD2cXovVCgtL0%3D 10.1161/01.STR.0000143319.73503.38 15375300 (Pubitemid 39458376)
6. U Laufs JK Liao 2000 Targeting Rho in cardiovascular disease Circ Res 87 7 526 528 1:CAS:528:DC%2BD3cXnt1Oqurk%3D 11009552
7. SSSS Investigators 1994 Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet. 344 1383 1389
8. J Shepherd SM Cobbe I Ford, et al. 1995 Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group N Engl J Med 333 1301 1307 1:CAS:528: DyaK28Xhslemsw%3D%3D 10.1056/NEJM199511163332001 7566020
9. P Amarenco J Bogousslavsky A Callahan, et al. 2006 High-Dose Atorvastatin after Stroke or Transient Ischemic Attack, The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators N Engl J Med 355 549 559 1:CAS:528:DC%2BD28XotVKgtb8%3D 10.1056/NEJMoa061894 16899775 (Pubitemid 44202151)
10. RN Bukkapatnam NB Gabler WR Lewis 2010 Statins for primary prevention of cardiovascular mortality in women: a systematic review and meta-analysis Prev Cardiol 13 2 84 90 1:CAS:528:DC%2BC3cXmt1ejtrY%3D 10.1111/j.1751-7141.2009. 00059.x 20377811
11. • Feher A, Pusch G, Koltai K, et al. Statin therapy in the primary and the secondary prevention of ischaemic cerebrovascular diseases. Int J Cardiol 2010 Sep 14. [Epub ahead of print]. This article discusses the benefits of statin therapy in primary and secondary prevention of stroke.
12. LX Cubeddu M Seamon 2006 Statin withdrawal: Clinical implications and molecular mechanisms Pharmacotherapy 26 9 1288 1296 1:CAS:528: DC%2BD28XpvFCksr4%3D 10.1592/phco.26.9.1288 16945051 (Pubitemid 44306889)
13. U Laufs M Endres F Custodis, et al. 2000 Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription Circulation 102 25 3104 1310 1:CAS:528:DC%2BD3MXitlSktg%3D%3D 11120702
14. S Westphal C Abletshauser C Luley 2008 Fluvastatin treatment and withdrawal: effects on endothelial function Angiology 59 5 613 618 1:CAS:528:DC%2BD1cXhtlGitbnO 10.1177/0003319708316005 18413332
15. RP Brandes S Beer T Ha R Busse 2003 Withdrawal of cerivastatin induces monocyte chemoattractant protein 1 and tissue factor expression in cultured vascular smooth muscle cells Arterioscler Thromb Vasc Biol 23 10 1794 1800 1:CAS:528:DC%2BD3sXnslWitro%3D 10.1161/01.ATV.0000092126.25380.BC 12933532 (Pubitemid 37254865)
16. RM Touyz El Schiffrin 2000 Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells Pharmacol Rev 52 4 639 672 1:CAS:528:DC%2BD3MXislWktg%3D%3D 11121512
17. AM Castejon E Zollner AG Tristano LX Cubeddu 2007 Upregulation of angiotensin II-AT1 receptors during statin withdrawal in vascular smooth muscle cells J Cardiovasc Pharmacol 50 6 708 711 1:CAS:528:DC%2BD2sXhsVCjt73P 10.1097/FJC.0b013e318157c0b2 18091590 (Pubitemid 350307043)
18. K Gertz U Laufs U Lindauer, et al. 2003 Withdrawal of statin treatment abrogates stroke protection in mice Stroke 34 2 551 557 1:CAS:528: DC%2BD3sXosVOhsQ%3D%3D 10.1161/01.STR.0000054055.28435.BF 12574574 (Pubitemid 36206363)
19. C Vecchione RP Brandes 2002 Withdrawal of 2-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors elicits oxidative stress and induces endothelial dysfunction in mice Circ Res 91 173 179 1:CAS:528:DC%2BD38XlvVCgsLs%3D 10.1161/01.RES.0000028004.76218.B8 12142351 (Pubitemid 34827229)
20. B Rosengarten D Auch M Kaps 2007 Effect of initiation and acute withdrawal of statins on the neurovascular coupling mechanism in healthy, normocholesterolemic humans Stroke 38 3193 3197 1:CAS:528:DC%2BD2sXhtlSlt7nN 10.1161/STROKEAHA.107.491423 17962596 (Pubitemid 350175736)
21. C Heeschen CW Hamm U Laufs, et al. 2002 Withdrawal of statins increases event rates in patients with acute coronary syndromes Circulation 105 1446 1452 1:CAS:528:DC%2BD38XjsVyrtbs%3D 10.1161/01.CIR.0000012530.68333.C8 11914253 (Pubitemid 34263276)
22. C Heeschen CW Hamm U Laufs, et al. 2003 Withdrawal of statins in patients with acute coronary syndromes Circulation 107 3 e27 10.1161/01.CIR.0000050552. 32300.93 12551886
23. FA Spencer GC Fonarow PD Frederick, et al. 2004 Early withdrawal of statin therapy in patients with non-ST-segment elevation myocardial infarction Arch Intern Med 164 2162 2168 1:CAS:528:DC%2BD2cXhtVaisbjJ 10.1001/archinte.164. 19.2162 15505131 (Pubitemid 39410807)
24. FA Spencer J Allegrone RJ Goldberg, et al. 2004 Association of statin therapy with outcomes of acute coronary syndromes: The GRACE study Ann Intern Med 140 857 866 15172899
25. F Colvicchi A Bassi M Santini C Caltagirone 2007 Discontinuation of statin therapy and clinical outcome after ischemic stroke Stroke 38 2652 2657 10.1161/STROKEAHA.107.487017 (Pubitemid 47493999)
26. M Blanco F Nombela M Castellanos, et al. 2007 Statin treatment withdrawal in ischemic stroke: a controlled randomized study Neurology 69 904 910 1:CAS:528:DC%2BD2sXptl2jsrY%3D 10.1212/01.wnl.0000269789.09277.47 17724294 (Pubitemid 47329591)
27. O Schouten SE Hoeks G Welten, et al. 2007 Effect of statin withdrawal on frequency of cardiac events after vascular surgery Am J Cardiol 100 316 320 1:CAS:528:DC%2BD2sXnslWhtbg%3D 10.1016/j.amjcard.2007.02.093 17631090 (Pubitemid 47041993)
28. Y Le Manach G Godet P Coriat, et al. 2007 The impact of postoperative discontinuation or continuation of chronic statin therapy on cardiac outcome after major vascular surgery Anesth Analg 104 1326 1333 10.1213/01.ane. 0000263029.72643.10 17513620 (Pubitemid 46795280)
29. Y Le Manach G Godet P Coriat, et al. 2007 The impact of postoperative discontinuation or continuation of chronic statin therapy on cardiac outcome after major vascular surgery Anesth Analg 104 1326 1333 10.1213/01.ane. 0000263029.72643.10 17513620 (Pubitemid 46795280)
30. K O'Neil-Callahan G Katsimaglis MR Tepper, et al. 2005 Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery: the statins for risk reduction in surgery (StaRRS) study Am J Cardiol 45 336 342 10.1016/j.jacc.2004.10.048 (Pubitemid 40186781)
31. AE Durazzo FS Machado DT Ikeoka, et al. 2004 Reduction in cardiovascular events alter vascular surgery with atorvastatin: a randomized trial J Vasc Surg 39 967 976 10.1016/j.jvs.2004.01.004 15111846 (Pubitemid 38581626)
32. PK Lindenauer P Pekow K Wang, et al. 2004 Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery JAMA 291 2092 2099 1:CAS:528:DC%2BD2cXjslegsbw%3D 10.1001/jama.291.17.2092 15126437 (Pubitemid 38580152)
33. R Risselada H Straatman F van Kooten, et al. 2009 Withdrawal of statins and risk of subarachnoid hemorrhage Stroke 40 2887 2892 1:CAS:528: DC%2BD1MXoslOltb8%3D 10.1161/STROKEAHA.109.552760 19520985 This article shows that recent withdrawal of statin therapy (< 30 days) is associated with increased risk of developing a subarachnoid hemorrhage
34. MP McGowan 2004 There is no evidence for an increase in acute coronary syndromes after short-term abrupt discontinuation of statins in stable cardiac patients Circulation 110 2333 2335 1:CAS:528:DC%2BD2cXosVSlsb4%3D 10.1161/01.CIR.0000145118.55201.15 15477411 (Pubitemid 39407335)
35. S Wassmann U Laufs AT Baumer K Muller C Konkol H Sauer M Bohm G Nickenig 2001 Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase Mol Pharmacol 59 3 646 654 1:CAS:528:DC%2BD3MXhs1OjsLY%3D 11179461
36. JJ Li YS Li J Chen JQ Yang 2006 Rebound phenomenon of inflammatory response may be a major mechanism responsible for increased cardiovascular events after abrupt cessation of statin therapy Med Hypotheses 66 6 1199 1204 1:CAS:528:DC%2BD28XivFSisb4%3D 10.1016/j.mehy.2005.06.035 16413682
37. D Poldermans JJ Bax MD Kertai, et al. 2003 Statins are associated with reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery Circulation 107 1848 1851 1:CAS:528: DC%2BD3sXis12qu7c%3D 10.1161/01.CIR.0000066286.15621.98 12695283 (Pubitemid 36444123)